Debiopharm, International

Debiopharm International SA United States of America Canada United Kingdom Belgium France Italy Netherlands Spain Switzerland

25.07.2017 - 08:02:34

Debiopharm International SA Awarded $2.6 Million Grant from CARB-X to Support Development of Debio 1453 to Fight Drug Resistant Gonorrhea

and follow us on Twitter @CARB_X.

About Debiopharm International SA 

Part of Debiopharm Group™ - a Swiss-headquartered global biopharmaceutical group including five companies active in the life science areas of drug development, GMP manufacturing of proprietary drugs, diagnostic tools and investment management - Debiopharm International SA is focused on the development of prescription drugs that target unmet medical needs. The company in-licenses and develops promising drug candidates. The products are commercialized by pharmaceutical out-licensing partners to give access to the largest number of patients worldwide.

For more information, please visit http://www.debiopharm.com

We are on Twitter. Follow us @DebiopharmNews at http://twitter.com/DebiopharmNews

Debiopharm International SA Contact
Christelle Tur
Communication Coordinator
christelle.tur@debiopharm.com
Tel: +41(0)21-321-01-11

Wellcome Trust Contact
Maggie Stratton
Media Manager
M.Stratton@wellcome.ac.uk
Tel. : +44(0)20-7611-8609
M. : +44(0)7872112656

Jennifer Robinson
jcrobinson119@icloud.com
Tel. : +1-514-914-8974

@ prnewswire.co.uk

Amazon wird sich schwarzärgern, aber …

… wir schenken Ihnen den Report „Börsenpsychologie - Markttechnik für Trader“ heute trotzdem kostenfrei. Normalerweise kostet der Report im Onlinehandel 39,99 Euro.

Sie können sich den genialen Report heute jedoch absolut kostenfrei sichern. Wir senden Ihnen den Report vollkommen KOSTENFREI zu.

Jetzt HIER klicken und dank richtigen Timing reich an der Börse werden!